These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 33459622)
1. Medical treatment of renal stones. López Martínez JM; Sierra Del Rio A; Luque Galvez MP Arch Esp Urol; 2021 Jan; 74(1):63-70. PubMed ID: 33459622 [TBL] [Abstract][Full Text] [Related]
2. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613 [TBL] [Abstract][Full Text] [Related]
3. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm. Tiselius HG; Daudon M; Thomas K; Seitz C Eur Urol Focus; 2017 Feb; 3(1):62-71. PubMed ID: 28720369 [TBL] [Abstract][Full Text] [Related]
4. KIDNEY STONE DISEASE WITH SPECIAL REGARD TO DRUG-INDUCED KIDNEY STONES - A CONTEMPORARY SYNOPSIS. Dobrek Ł Wiad Lek; 2020; 73(9 cz. 2):2031-2039. PubMed ID: 33148855 [TBL] [Abstract][Full Text] [Related]
5. Comparison of current guidelines on medical management of stone disease. Tzelves L; Mourmouris P; Skolarikos A Arch Esp Urol; 2021 Jan; 74(1):171-182. PubMed ID: 33459633 [TBL] [Abstract][Full Text] [Related]
6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]
7. Urinary tract infection's etiopathogenic role in nephrolithiasis formation. Bauza JL; Pieras EC; Grases F; Tubau V; Guimerà J; Sabaté XA; Pizà P Med Hypotheses; 2018 Sep; 118():34-35. PubMed ID: 30037611 [TBL] [Abstract][Full Text] [Related]
8. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Türk C; Petřík A; Sarica K; Seitz C; Skolarikos A; Straub M; Knoll T Eur Urol; 2016 Mar; 69(3):468-74. PubMed ID: 26318710 [TBL] [Abstract][Full Text] [Related]
9. 24 Hour urine metabolic differences between solitary and multiple stone formers: Results of the Collaboration on Urolithiasis in Pediatrics (CUP) working group. Saitz TR; Mongoue-Tchokote S; Sharadin C; Giel DW; Corbett S; Kovacevic L; Bayne AP; J Pediatr Urol; 2017 Oct; 13(5):506.e1-506.e5. PubMed ID: 28526618 [TBL] [Abstract][Full Text] [Related]
10. The role of the general practictioner in the management of urinary calculi. Prezioso D; Piccinocchi G; Abate V; Ancona M; Celia A; De Luca C; Ferrari R; Ferraro PM; Mancon S; Mazzon G; Micali S; Puca G; Rendina D; Saita A; Salvetti A; Spasiano A; Tesè E; Trinchieri A Arch Ital Urol Androl; 2023 Dec; 95(4):12155. PubMed ID: 38193217 [TBL] [Abstract][Full Text] [Related]
11. Obesity and urolithiasis: evidence of regional influences. Trinchieri A; Croppi E; Montanari E Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444 [TBL] [Abstract][Full Text] [Related]
12. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors. Schwille PO; Wipplinger J Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191 [TBL] [Abstract][Full Text] [Related]
13. Medical treatment of urinary stones. Skolarikos A Curr Opin Urol; 2018 Sep; 28(5):403-407. PubMed ID: 29939860 [TBL] [Abstract][Full Text] [Related]
14. [Functional evaluation in patients with kidney calculi]. Stojimirović B Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414 [TBL] [Abstract][Full Text] [Related]
15. Established and recent developments in the pharmacological management of urolithiasis: an overview of the current treatment armamentarium. Abou Chakra M; Dellis AE; Papatsoris AG; Moussa M Expert Opin Pharmacother; 2020 Jan; 21(1):85-96. PubMed ID: 31714803 [No Abstract] [Full Text] [Related]
16. 2022 Recommendations of the AFU Lithiasis Committee: Medical management - from diagnosis to treatment. Lemoine S; Dahan P; Haymann JP; Meria P; Almeras C; Prog Urol; 2023 Nov; 33(14):911-953. PubMed ID: 37918992 [TBL] [Abstract][Full Text] [Related]
17. Obesity and kidney stone disease: a systematic review. Carbone A; Al Salhi Y; Tasca A; Palleschi G; Fuschi A; De Nunzio C; Bozzini G; Mazzaferro S; Pastore AL Minerva Urol Nefrol; 2018 Aug; 70(4):393-400. PubMed ID: 29856171 [TBL] [Abstract][Full Text] [Related]
18. Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: An EAU Guidelines Update. Skolarikos A; Somani B; Neisius A; Jung H; Petřík A; Tailly T; Davis N; Tzelves L; Geraghty R; Lombardo R; Bezuidenhout C; Gambaro G Eur Urol; 2024 Oct; 86(4):343-363. PubMed ID: 39069389 [TBL] [Abstract][Full Text] [Related]
19. [Stone therapy-use and limitations of the guidelines]. Seitz C; Türk C; Neisius A Urologe A; 2020 Dec; 59(12):1498-1503. PubMed ID: 33237370 [TBL] [Abstract][Full Text] [Related]
20. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers. Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]